Method
Subjects
The subjects were 102 experimentally naïve, adult male Sprague Dawley rats, purchased from Harlan Sprague Dawley Laboratories (Indianapolis, IN). The animals were delivered to the laboratory at approximately 21 days of age and 42 g. They were maintained under ad libitum food and water until they were approximately 90 days of age and 300 g, at which point the experimental procedures were initiated (see below). The procedures recommended by the National Research Council (1996), the Committee on Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research (2003), and the Institutional Animal Care and Use Committee at American University were followed at all times.
Apparatus
Throughout the conduct of the research, all subjects were individually housed in hanging wire-mesh cages (25.4 × 20 × 18.4 cm), on the front of which graduated Nalgene tubes could be placed for fluid presentation. The subjects were maintained on a 12:12 light:dark cycle (lights on at 0800 h) and at an ambient temperature of 23 °C. The place-conditioning apparatus (San Diego Instruments Place Preference System, San Diego, CA) consisted of two main conditioning chambers (28 × 21 × 34.5 cm) joined by a smaller middle chamber (14 × 21 × 34.5 cm). One of the conditioning chambers featured a white aluminum diamond plate floor with white walls; the other conditioning chamber featured a hair-cell-textured black plastic floor with black walls; the smaller middle chamber was outfitted with a steel rod floor and gray walls. Each individual chamber in each apparatus had its own white LED lights, and the lights were set on minimum. The room in which the chambers were located was illuminated by a 25-W red light mounted to the ceiling, and a white noise generator was used to mask background noise. A total of eight identical apparatuses were used; each apparatus featured a 16 × 4 photo-beam array for recording time (in seconds) in each chamber.
Drugs
Morphine sulfate (generously supplied by NIDA) was dissolved in sterile isotonic saline (0.9 %) at a concentration of 5 mg/ml and administered subcutaneously (sc) at a dose of 5 mg/kg. Saccharin (0.1 % sodium saccharin, Sigma Chemical Co.) was prepared as a 1 g/L solution in tap water. All drug weights are expressed as the salt form.
Procedure
Phase 1: Habituation
On Day 1 of this phase, subjects were water deprived. Following 23 2/3 h of water deprivation, they were given 20-min access to tap water daily. This procedure was repeated until consumption stabilized—that is, subjects approached and drank from the tube within 2 s of its presentation, and water consumption was within 2 ml of that from the previous day for a minimum of four consecutive days with no consistent increase or decrease.
Phase 2: Taste aversion conditioning
Once consumption stabilized, animals were ranked on average water consumption over the last 3 days of habituation and assigned to one of two groups [i.e., Group S (n = 51) and Group W (n = 51)], such that consumption was comparable between the groups. On Day 1 of this phase, subjects in Group S were given access to a novel saccharin solution in place of water during their regular 20-min fluid access. Immediately following this presentation, animals in this group were ranked on fluid consumption and assigned to one of two treatment groups (n = 25/26), such that the overall consumption was comparable between groups. Approximately 5 min after fluid access, subjects in Group S-M received an sc injection of morphine (5 mg/kg), whereas Group S-V received equivolume saline. Subjects in Group W were given 20-min access to water on this day, assigned to one of two groups (W-M and W-V) on the basis of water consumption, and given an sc injection of 5 mg/kg morphine or equivolume saline, respectively, 5 h after fluid access. The latter procedure was used to give subjects comparable exposure to the injection/drug without an aversion history—that is, administering morphine 5 h after water access is not a condition sufficient to establish a taste aversion (see Freeman & Riley, 2005; Riley, Jacobs, & Mastropaolo, 1983; Lubow, 2009). On the following 3 days (water recovery), all groups were given 20-min access to water (no injections followed this access). This alternating procedure of conditioning and water recovery was repeated for a total of five complete cycles.
Phase 3: Place preference conditioning
On Day 1 of this phase (the day after the third water-recovery day of the fifth conditioning cycle; see above), all subjects were given free access to a place preference chamber for 15 min in order to assess initial side preference—that is, the relative time spent in each compartment. A paired-samples t test revealed no significant preference for either side [mean time: white → 300.71 s, black → 330.17 s; t(101) = −1.788, p > .05]. Thus, during subsequent place preference conditioning, an unbiased training procedure (see Cunningham, Ferree, & Howard, 2003; Roma & Riley, 2005) was used, during which the drug was randomly associated with either the black or the white side. On the first place preference conditioning session, subjects were injected (sc) with either morphine (5 mg/kg) or equivolume saline (counterbalanced within each group) and placed in one chamber of the conditioning apparatus (drug-paired side, DPS) for 30 min. This yielded eight groups: specifically, Groups S-M/M (n = 14), S-M/V (n = 12), S-V/M (n = 13), S-V/V (n = 12), W-M/M (n = 14), W-M/V (n = 12), W-V/M (n = 13), and W-V/V (n = 12), where S or W refers to the fluid given during taste aversion conditioning (saccharin or water), the first M or V refers to the injection (morphine or vehicle) given during taste aversion conditioning, and the second M or V refers to the injection given during place preference conditioning. On the following day, all animals were injected with equivolume saline and placed in the opposite chamber (nondrug paired side, NDPS) for 30 min. This 2-day cycle was then repeated. On the fifth day (Test 1), all animals were placed in the place preference apparatus for 15 min and allowed to explore both compartments. The time spent in each compartment was recorded for each animal. On the day following this test, all animals were again injected with either morphine (5 mg/kg) or equivolume saline and placed in the DPS of the conditioning apparatus for 30 min. On the following day, they were injected with equivolume saline and placed in the NDPS for 30 min. This 2-day cycle was again repeated and followed on the next day by a second place preference test (Test 2), in which all animals were placed in the place preference apparatus for 15 min and allowed to explore both compartments. As above, the time spent in each compartment was recorded for each animal.
Statistical analyses
During taste aversion conditioning, differences in fluid consumption among the groups were assessed with a 2 × 2 × 5 mixed model analysis of variance (ANOVA), with the between-subjects variables preexposure fluid (saccharin or water) and preexposure drug (morphine or vehicle) and the within-subjects variable trial (1–5). One-way ANOVAs were run for each trial, followed by Tukey’s post-hoc analyses to assess differences in consumption among the groups. To evaluate any within-subjects differences across trials, paired-samples t tests with Bonferroni corrections were run for each group, comparing the baseline fluid consumption to consumption on each subsequent trial (p ≤ .05/16, or .003125). During place preference conditioning, the time (in seconds) spent on the DPS on Pretest, Test 1, and Test 2 was analyzed using a 4 × 2 × 3 mixed model ANOVA with the between-subjects variables aversion history (S-M, S-V, W-M, and W-V) and CPP drug (morphine or vehicle), and the within-subjects variable test (pretest, Test 1, and Test 2). Subsequent one-way ANOVAs were run for each test in order to assess differences in time spent on the DPS among groups. All significance levels were set at p ≤ .05.
Results
Phase 2: Taste aversion conditioning
Figure 1 illustrates saccharin (Groups S-M and S-V) or water (Groups W-M and W-V) consumption for all groups over the five conditioning trials in Phase 2. As is illustrated, animals receiving saccharin paired with morphine acquired significant aversions relative to all other groups and to their own baseline. The 2 × 2 × 5 mixed measures ANOVA on fluid consumption revealed effects of preexposure fluid [F(1, 98) = 18.865, p < .001], preexposure drug [F(1, 98) = 101.733 p < .001], and trial [F(4, 392) = 11.134, p < .001], as well as significant Preexposure Drug × Trial [F(4, 392) = 36.561, p < .001], Preexposure Fluid × Preexposure Drug [F(1, 98) = 107.471, p < .001], and Preexposure Fluid × Preexposure Drug × Trial [F(4, 392) = 39.043, p < .001] interactions. In relation to the significant Preexposure Fluid × Preexposure Drug × Trial interaction, Tukey’s post-hoc analyses revealed that Groups S-M and S-V differed significantly in baseline saccharin consumption on Trial 1, p = .045. We found no differences among Groups S-V, W-M, and W-V on this trial. On all subsequent trials, Group S-M drank significantly less than all other groups (all ps ≤ .05). Furthermore, Group S-V drank significantly more fluid than Groups W-M and W-V (all ps ≤ .05). Groups W-M and W-V did not differ from each other on any trial (all ps > .05).
Paired-samples t tests revealed that Group S-M significantly decreased saccharin consumption from baseline (Trial 1) on all subsequent trials (all ps ≤ .003125). Group S-V significantly increased consumption from baseline (Trial 1) on all subsequent trials (all ps ≤ .003125). Groups W-M and W-V showed no significant changes in water consumption over conditioning (all ps > .003125).
Phase 3: Place preference test
Figure 2 illustrates the time, in seconds, spent on the drug-paired side for each group during the baseline test, as well as any changes in this time from Test 1 to Test 2. As is illustrated, independent of aversion history, animals injected with morphine during place preference conditioning significantly increased their time spent on the DPS, indicating that place preferences were acquired. Furthermore, these increases were comparable for all groups. The 4 × 2 × 3 mixed-model ANOVA on time spent on the DPS revealed significant effects of CPP drug [F(1, 94) = 44.377, p < .001] and test [F(2, 188) = 39.07, p < .001], as well as a significant CPP Drug × Test interaction [F(2, 188) = 35.571, p < .001]. In relation to the significant CPP Drug × Test interaction, subsequent one-way ANOVAs were run on each test (pretest, Test 1, and Test 2) to assess specific group differences. On the pretest, we observed no significant effect of CPP drug (collapsed across aversion histories) [F(7, 101) = 1.089, p = .377]. Significant differences were evident on Test 1 and Test 2. Specifically, on Test 1, animals injected with morphine during place preference conditioning spent significantly greater time on the DPS than did animals injected with vehicle [F(7, 101) = 6.255, p < .001]. This difference was also noted on Test 2 [F(7, 101) = 11.799, p < .001]. Although morphine induced place preferences, no significant effect emerged of aversion history [F(3, 94) = 2.265, p > .05], nor any interaction with this term as a factor (all Fs < 3, all ps > .05), indicating that a history with taste aversions did not affect the rate or strength of place preference acquisition.
Discussion
To assess whether a history of taste aversion learning with morphine would impact the subsequent acquisition of morphine-induced place preference conditioning, animals in the present experiment were given pairings of saccharin with morphine (taste aversion training) immediately prior to place preference conditioning (with morphine). The data from these animals were compared to data from various controls matched in taste or drug experience, but without the aversion training history. If morphine has both aversive and rewarding effects, but the response conditioned is a function of the specific stimuli with which morphine is paired, both taste aversions and place preferences should be evident. As we reported, taste aversion learning did not impact the ability of morphine to condition preferences; that is, animals displayed both conditioned responses.
The failure of aversion conditioning to affect the acquisition of place preferences was not a simple function of the inability of the specific procedures utilized in the present experiment to induce such effects. First, animals given repeated pairings of saccharin and morphine acquired robust taste aversions, significantly decreasing their saccharin consumption relative to controls, and to their own baseline. Second, all groups given morphine during place preference conditioning acquired place preferences relative to vehicle-treated controls. The fact that a history of aversion learning did not impact place preference conditioning argues instead that morphine has multiple effects and that the specific stimuli present during conditioning are selectively associated with these effects (aversive and rewarding) and differentially control avoidance or preference.
Although this interpretation is possible, it is important to note that the findings in Experiment 1 were similar procedurally to others in associative learning, whereby a sequential history with one unique association (A→X) has no impact on a second association in which the same US is given—that is, B → X (Domjan & Burkhard, 1982). In such work, there is no interference between the two associations, given that the associative strength of the US is accrued to each stimulus and to the same degree. Accordingly, the failure of morphine aversion conditioning to affect place preference conditioning with morphine might be expected, and not be a function of its dual affective properties being selectively associated with specific taste and environmental stimuli.
If the failure of aversion conditioning to affect place preference conditioning in Experiment 1 was a function of processes operating in traditional associative conditioning (see above), it might be expected that place preference conditioning with morphine would be impacted (i.e., blocked) if such conditioning were attempted in the presence of a taste previously associated with that same morphine (Westbrook & Brookes, 1988). Under this condition, no added information would be provided by the redundant place cues. On the other hand, if morphine has multiple stimulus effects, each of which is selectively associated with specific stimuli, a taste aversion conditioning history with morphine should have no effect on subsequent morphine-induced place preference conditioning, even when such conditioning occurred in the presence of the previously conditioned taste cues. These predictions were tested in Experiment 2, in which a modified blocking design was used to examine the interaction of taste aversion and place preference conditioning with morphine.